On July 2, I wrote about the United States government’s new version of Operation Warp Speed undertaken in the name of countering bird flu. An early component of the new program for expedited bird flu mRNA shots development, I noted, involved the US government providing 176 million dollars to Moderna. All indications were that other companies would also be diving in for dollars as this program and other bird flu related government actions progress.
Megan Redshaw provided more information about what Moderna is up to with its government-provided cash in her Tuesday article at Reform Pharma. The article, titled “Feds Sink Millions Into mRNA Bird Flu Vaccine to Prepare for Hypothetical Pandemic,” begins where my earlier writing left off:
With the COVID-19 pandemic in the rearview mirror, the U.S. government is preparing for the next big thing as it sinks millions into an mRNA vaccine for a virus that currently poses little risk to humans.
Throwing all caution to the wind with a questionable technology linked to every condition from heart inflammation and prion diseases to aggressive cancers and death, the U.S. government recently awarded Moderna $176 million in funding to support the late-stage clinical trial of its mRNA bird flu vaccine. The award is part of a broader strategy to prepare for a hypothetical pandemic driven by avian flu.
From there, Redshaw proceeds to providing dismal details of how Moderna, as before with the coronavirus “vaccine” shots, is conducting its drug development in a manner far short of what is needed to instill confidence that the outcome will be new shots that really are “safe and effective.”
Continue reading Redshaw’s article here.
